EUCTR2011-002144-27-NL进行中(未招募)不适用
A Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Study Comparing the Safety and Analgesic Efficacy of ABT-110 to Placebo in Subjects with Pain from Osteoarthritis of the Knee
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 390
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Subject is between 18 and 70 years of age, inclusive.
- •2. Osteoarthritis pain in the index knee which meets the following:
- •? History of pain in the index knee = 6 months; AND
- •? K-L Grade 2 or 3 only on plain radiographs of the index knee; AND
- •? At least 1 of the following 3 criteria:
- •? Age > 50 years; OR
- •? Stiffness < 30 minutes upon awakening; OR
- •? Crepitus in the index knee.
- •3. Subject must meet the following pain criteria at the time of the Baseline Visit:
- •? Subject's Assessment of Arthritis Pain Intensity (VAS) of the index knee is = 40 mm with an increase of = 10 mm from the Screening Visit,
- •o For subjects whose Screening VAS is = 85 mm, a VAS of = 85 mm must be maintained at the Baseline Visit; AND
- •? Subject's Global Assessment of Arthritis Status must be Fair, Poor or Very Poor.
- •4. Subject requires therapeutic doses of at least 1 non-opioid analgesic for OA pain for at least 4 days per week during the 4 weeks prior to the Screening Visit.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 310
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 80
排除标准
- •1. Subject is scheduled for or is considering joint replacement surgery within 6 months following the Screening Visit.
- •2. Subject has had any of the following:
- •? Joint replacement/reconstruction to the index joint at any time;
- •? Any major surgery, e.g., open surgery, to the index joint within 12 months
- •prior to the Screening Visit; OR
- •? Arthroscopic surgery to the index joint within 3 months prior to the Screening
- •3. Subject has a history of osteonecrosis in any joint.
- •4. Subject has OA of the knee that meets the K-L classification criteria of grade 0, 1
研究者
相似试验
进行中(未招募)
不适用
A Study Comparing the Safety and Analgesic Efficacy of ABT-110 inSubjects with Pain from Osteoarthritis of the KneeEUCTR2011-002144-27-PLAbbVie Deutschland GmbH & Co. KG350
进行中(未招募)
不适用
A Study Comparing the Safety and Analgesic Efficacy of ABT-110 inSubjects with Pain from Osteoarthritis of the KneePain from Osteoarthritis of the KneeMedDRA version: 15.1Level: LLTClassification code 10031165Term: Osteoarthritis kneeSystem Organ Class: 100000004859EUCTR2011-002144-27-FIAbbVie Deutschland GmbH & Co. KG330
进行中(未招募)
不适用
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects with Diabetic Neuropathic PaiEUCTR2010-024359-99-DEAbbott GmbH & Co. KG180
进行中(未招募)
不适用
A Study Comparing the Safety and Analgesic Efficacy of ABT-110 in Subjects with Pain from Osteoarthritis of the KneePain from Osteoarthritis of the KneeMedDRA version: 14.1Level: LLTClassification code 10031165Term: Osteoarthritis kneeSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-002144-27-ITABBOTT GMBH & Co. KG390
进行中(未招募)
不适用
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects with Diabetic Neuropathic PaiDiabetic Neuropathic PainMedDRA version: 14.0Level: LLTClassification code 10067547Term: Diabetic peripheral neuropathic painSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-024359-99-CZAbbott GmbH & Co. KG180
